Longitudinal ctDNA monitoring for post-surgical molecular residual disease in patients with stage I-IIIb melanoma

Ansstas et al, ASCO 2025

Predicting nodal burden after neoadjuvant chemotherapy (NAC) with circulating tumor (ct)DNA for surgical planning: Results from the I-SPY2 t

Mukhtar et al, ASCO 2025

Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC)

Razavi et al, ASCO 2025

Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy

Pusztai et al, ASCO 2025

Zaanan 2025 Nature Communications

Abdelrahim 2025 ctDNA and HCC

Nasca et al. TRINITY Study Protocol - 2025 BMC Cancer

Zhang et al. Pancreatic Cancer - Biomedicines 2025

Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants

Souter, Vivienne; et al. J Genet Couns. 2025

Incidental finding of maternal sex chromosome aneuploidy from DMD carrier screening and single-nucleotide polymorphism (SNP)-based prenatal

Walker, J et al. J Genet Couns. 2025

A Two-Threshold Algorithm using Donor-derived Cell-free DNA Fraction and Quantity to Detect Acute Rejection After Heart Transplantation

Evaluating Reproductive Carrier Screening using Biotinidase Deficiency as a Model: Variants Identified, Variant Rates and Management

Poor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testing

Chromosome segregation of human nonhomologous Robertsonian translocations: insights from preimplantation genetic testing

Accuracy of fetal fraction measurements in a single nucleotide polymorphismbased noninvasive prenatal test

Role of genetic analysis of products of conception and PGT in managing early pregnancy loss

The Role of cfDNA Biomarkers and Patient Data in the Early Prediction of Preeclampsia: Artificial Intelligence Model

Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United States

Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort

Gilstrop Thompson, et al. OBSTETRICS & GYNECOLOGY 2024